Familial risks and temporal incidence trends of multiple myeloma

European Journal of Cancer

Volumn 42, Issue 11, 2006, Pages 1661-1670

  Altieri, Andrea ^a   Chen, Bowang ^a   Bermejo, Justo Lorenzo ^a   Castro, Felipe ^a   Hemminki, Kari ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Familial risk; Hereditary factors; Incidence; Multiple myeloma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CERTIFICATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL OBSERVATION; CLUSTER ANALYSIS; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RECTUM CANCER; RISK ASSESSMENT; STANDARDIZATION; STOMACH CANCER; SWEDEN; TIME SERIES ANALYSIS; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PEDIGREE; TIME FACTORS;

EID: 33746364172     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.11.033     Document Type: Article

References (71)

1. Grogan T.M., Müller-Hermelink H.K., Van Camp B., Harris N.L., and Kyle R.A. Plasma cell neoplasms. In: Jaffe S.E., Vardiman J.W., Stein H., and Harris N.L. (Eds). Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues (2001), International Agency for Research on Cancer (IARC) Press, Lyon, France 142-156
2. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 (2004) 3-27
3. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
4. Tavani A., Pregnolato A., Negri E., et al. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27 (1997) 256-260
5. Gramenzi A., Buttino I., D'Avanzo B., et al. Medical history and the risk of multiple myeloma. Br J Cancer 63 (1991) 769-772
6. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer 101 (2004) 2667-2674
7. Levi F., Lucchini F., Negri E., Boyle P., and La Vecchia C. Changed trends of cancer mortality in the elderly. Ann Oncol 12 (2001) 1467-1477
8. Levi F., Lucchini F., Negri E., Boyle P., and La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 110 (2004) 155-169
9. Levi F., Te V.C., Randimbison L., and La Vecchia C. Incidence of multiple myeloma in Olmsted County, Minnesota. Cancer (2005)
10. Hemminki K., and Li X. Cancer risks in Nordic immigrants and their offspring in Sweden. Eur J Cancer 38 (2002) 2428-2434
11. Iscovich J., and Howe G.R. Cancer incidence patterns (1972-91) among migrants from the Soviet Union to Israel. Cancer Causes Control 9 (1998) 29-36
12. Swerdlow A.J., Marmot M.G., Grulich A.E., and Head J. Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br J Cancer 72 (1995) 1312-1319
13. Alexander L.L., and Benninghoff D.L. Familial multiple myeloma. II. Final pathological findings in two brothers and a sister. J Natl Med Assoc 59 (1967) 278-281
14. Altieri A., Bermejo J.L., and Hemminki K. Familial risk of non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype from the Swedish family-cancer database. Blood (2005)
15. Bourguet C.C., Grufferman S., Delzell E., DeLong E.R., and Cohen H.J. Multiple myeloma and family history of cancer. A case-control study. Cancer 56 (1985) 2133-2139
16. Brown L.M., Linet M.S., Greenberg R.S., et al. Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer 85 (1999) 2385-2390
17. Chatterjee N., Hartge P., Cerhan J.R., et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, haematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13 (2004) 1415-1421
18. Crozes-Bony P., Palazzo E., Meyer O., De Bandt M., and Kahn M.F. Familial multiple myeloma. Report of a case in a father and daughter. Review of the literature. Rev Rhum Engl Ed 62 (1995) 439-445
19. Eriksson M., and Bergstrom I. Familial malignant blood disease in the country of Jamtland, Sweden. Eur J Haematol 38 (1987) 241-245
20. Eriksson M., and Hallberg B. Familial occurrence of haematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes Control 3 (1992) 63-67
21. Grosbois B., Jego P., Attal M., et al. Familial multiple myeloma: report of fifteen families. Br J Haematol 105 (1999) 768-770
22. Horwitz L.J., Levy R.N., and Rosner F. Multiple myeloma in three siblings. Arch Intern Med 145 (1985) 1449-1450
23. Judson I.R., Wiltshaw E., and Newland A.C. Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol 60 (1985) 551-554
24. Lynch H.T., Sanger W.G., Pirruccello S., Quinn-Laquer B., and Weisenburger D.D. Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 93 (2001) 1479-1483
25. Maldonado J.E., and Kyle R.A. Familial myeloma. Report of eight families and a study of serum proteins in their relatives. Am J Med 57 (1974) 875-884
26. Shoenfeld Y., Berliner S., Shaklai M., Gallant L.A., and Pinkhas J. Familial multiple myeloma. A review of thirty-seven families. Postgrad Med J 58 (1982) 12-16
27. Sobol H., Vey N., Sauvan R., et al. Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 94 (2002) 461-462
28. The National Board of Health and Welfare (Socialstyrelesen). Cancer incidence in Sweden, 2000. Stockholm: 2002.
29. Zheng T.Z., Mayne S.T., and Flannery J. The time trends of multiple myeloma in Connecticut, 1935-1987. Int J Cancer 50 (1992) 163-164
30. Levi F., and La Vecchia C. Trends in multiple myeloma. Int J Cancer 46 (1990) 755-756
31. Turesson I., Zettervall O., Cuzick J., Waldenstrom J.G., and Velez R. Comparison of trends in the incidence of multiple myeloma in Malmo, Sweden, and other countries, 1950-1979. N Engl J Med 310 (1984) 421-424
32. Lynch H.T., Watson P., Tarantolo S., et al. Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol 23 (2005) 685-693
33. Zawadzki Z.A., Aizawa Y., Kraj M.A., Haradin A.R., and Fisher B. Familial immunopathies: report of nine families and survey of literature. Cancer 40 (1977) 2094-2101
34. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000) 78-85
35. McCrea A.P., and Morris T.C. Concurrent familial myeloma in Northern Ireland. Cancer 58 (1986) 394-396
36. Goldgar D.E., Easton D.F., Cannon-Albright L.A., and Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86 (1994) 1600-1608
37. Kerber R.A., and O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103 (2005) 1906-1915
38. Paltiel O., Schmit T., Adler B., et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer 88 (2000) 2357-2366
39. Dong C., and Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92 (2001) 144-150
40. Goldin L.R., Pfeiffer R.M., Gridley G., et al. Familial aggregation of Hodgkin lymphoma and related tumours. Cancer 100 (2004) 1902-1908
41. Levi F., Randimbison L., Te V.C., Franceschi S., and La Vecchia C. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol 11 (2000) 957-963
42. Morgan G.J., and Davies F.E. Evolving treatment strategies for myeloma. Br J Cancer 92 (2005) 217-221
43. Deshpande H.A., Hu X.P., Marino P., Jan N.A., and Wiernik P.H. Anticipation in familial plasma cell dyscrasias. Br J Haematol 103 (1998) 696-703
44. Daugherty S.E., Pfeiffer R.M., Mellemkjaer L., Hemminki K., and Goldin L.R. No evidence for anticipation in lymphoproliferative tumours in population-based samples. Cancer Epidemiol Biomarkers Prev 14 (2005) 1245-1250
45. Devesa S.S., Silverman D.T., Young Jr. J.L., et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 79 (1987) 701-770
46. Leech S.H., Bryan C.F., Elston R.C., et al. Genetic studies in multiple myeloma. 1. Association with HLA-Cw5. Cancer 51 (1983) 1408-1411
47. Kuehl W.M., and Bergsagel P.L. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2 (2002) 175-187
48. Magrangeas F., Lode L., Wuilleme S., Minvielle S., and Avet-Loiseau H. Genetic heterogeneity in multiple myeloma. Leukaemia 19 (2005) 191-194
49. Meijers K.A., De Leeu M.B., and Voormolen-Kalova M. The multiple occurrence of myeloma and asymptomatic paraproteinaemia within one family. Clin Exp Immunol 12 (1972) 185-193
50. IARC. Cancer Incidence, Mortality and Prevalence in the European Union. Lyon: 1999.
51. Hemminki K., Li X., Plna K., Granstrom C., and Vaittinen P. The nation-wide Swedish family-cancer database-updated structure and familial rates. Acta Oncol 40 (2001) 772-777
52. Esteve J., Raymond L., and Benhamou E. Statistical methods in cancer research. Descriptive epidemiology Volume IV (1994), IARC Sci Publ
53. Hemminki K., and LI X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 110 (2004) 291-294
54. Hemminki K., and Chen B. Familial association of colorectal adenocarcinoma with cancers at other sites. Eur J Cancer 40 (2004) 2480-2487
55. Dilworth D., Liu L., Stewart A.K., et al. Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood 95 (2000) 1869-1871
56. Debniak T., Gorski B., Scott R.J., et al. Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer 110 (2004) 558-562
57. Lorenzo Bermejo J., Rawal R., and Hemminki K. Familial association of specific histologic types of ovarian malignancy with other malignancies. Cancer 100 (2004) 1507-1514
58. Hemminki K., and Dong C. Familial prostate cancer from the family-cancer database. Eur J Cancer 36 (2000) 229-234
59. Eriksson M., and Karlsson M. Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med 49 (1992) 95-103
60. Lee W.J., Baris D., Jarvholm B., et al. Multiple myeloma and diesel and other occupational exposures in swedish construction workers. Int J Cancer 107 (2003) 134-138
61. Lewis E.B. Leukaemia, Multiple Myeloma, and Aplastic Anaemia in American Radiologists. Science 142 (1963) 1492-1494
62. Linet M.S., Harlow S.D., and McLaughlin J.K. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res 47 (1987) 2978-2981
63. Rusiecki J.A., De Roos A., Lee W.J., et al. Cancer incidence among pesticide applicators exposed to atrazine in the Agricultural Health Study. J Natl Cancer Inst 96 (2004) 1375-1382
64. Waterhouse D., Carman W.J., Schottenfeld D., Gridley G., and McLean S. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms. Cancer 77 (1996) 763-770
65. Ende M. Multiple myeloma: a cluster in Virginia?. Va Med 106 (1979) 115-116
66. Kyle R.A., Heath Jr. C.W., and Carbone P. Multiple myeloma in spouses. Arch Intern Med 127 (1971) 944-946
67. Kyle R.A., Finkelstein S., Elveback L.R., and Kurland L.T. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 40 (1972) 719-724
68. Kyle R.A., and Greipp P.R. Multiple myeloma. Houses and spouses. Cancer 51 (1983) 735-739
69. Linet M.S. Chronic lymphocytic leukaemia and multiple myeloma in husband and wife. Am J Med Sci 288 (1984) 21-24
70. Hemminki K., Dong C., and Vaittinen P. Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 20 (2001) 247-257
71. Hemminki K., and Eng C. Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet 41 (2004) 801-807